Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleRed Hat
CEO ReviewCompany Review

The Silicon Review Asia

ICMR Creates Vaccine for Shigella, Licenses to Hilleman Laboratories

ICMR Creates Vaccine for Shigella, Licenses to Hilleman Laboratories

The first ever vaccine for Shigella, an intestinal disease has been licensed by the Indian Council of Medical Research (ICMR) on April 23 this year. The license agreement was carried out by India Limited (BCIL), a Biotech Consortium with NICED on behalf of Hilleman laboratories and ICMR.

The licensed vaccine was given to MSD Wellcome Trust Hilleman Laboratories Pvt Ltd for further scaling up and commercialisation.

The new breakthrough was carried out ICMR-National Institute of Cholera and Enteric Diseases (NICED). The new vaccine for Shigella was created in the form of heat-treated/formalin killed vaccines. Apart from that, another next-gen vaccine such as OmpA nano-formulation and OMVs (Outer Membrane Vesicles) is also being created to control the spread the Shigella infection.

The bodies involved in the creation of the licensed vaccine candidate are ICMR, Japan’s Okayama University and National Institute of Infectious Diseases. The translation of the licensed vaccine candidate will go through a stringent pre-clinical and clinical development before hitting the market for use.

The Shigella vaccine which has high potential should help the children hailing from low and mid-income families.

The new development is the first ever vaccine produced to treat Shigella. Currently, the world wide treatment for the disease is being treated through antibiotics; therefore, the major concern on antibiotic resistance and global emergence makes the new vaccine the only solution for the disease.

The new development is a big achievement for ICMR.


Pine Labs Reaffirms its Commitment to Indian Payments Space with Qfix Acquisition

HDFC Bank is Qfix's main distribution partner Pine Labs has announced that it has acquired Qfix, a Mumbai-based online payments startup. This acquisi...

Salesforce Expands into Thailand, Opens Office in Bangkok

Salesforce has announced permanent presence in Thailand by launching its new office in the country’s capital, Bangkok. The permanent presence wi...

GMLL is expected to soon add two more stores to its retail arm ‘Price Mantra’

Garment Mantra Lifestyle, a popular name in the Indian fashion retail segment, recently made an announcement that the company is expanding its retail ...

Tariff plans will cost higher from the next financial year as telecom companies are gearing up to increase rates

The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...